ARCHIVES

Guest Editorial: Even Slam-Dunk Applications Can Benefit From Public Scrutiny and Discussion at ODAC

This article is from The Cancer Letter archive.

Vol. 38 No. 32 | August 10, 2012

Download PDF Visit The Full Archive

Related Articles

NIH Electronic Grant Coding System Worse Than NCI’s Manual Method, Advocates Say.

September 5, 2008

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

October 26, 2012

NCI Restructures AIDS Effort; New Research Thrusts Recommended

October 5, 1984

Prostate Cancer: NIH Pans To Ramp Up Prostate Cancer Research Funding

June 25, 1999

In Congress: Bill Introduced In House On Payment for Patient Care Costs In Trials; Senate Defeats Bill To Cut Teen Smoking

May 23, 1997

EntreMed Begins Phase I/II Trial For Endostatin.

July 27, 2001